Health Insurance Innovations Accused of Deceiving Investors Over Denied License
by Erin Shaak
Last Updated on May 8, 2018
Cioe Investments Inc. v. Health Insurance Innovations, Inc. et al
Filed: September 11, 2017 ◆§ 8:17cv2980
Health Insurance Innovations, Inc., its CEO, and its CFO are facing claims that they failed to disclose material information to stockholders regarding the company’s application for a third-party insurance administrator license in Florida.
New York
An investor has filed a proposed class action lawsuit against Health Insurance Innovations, Inc., its CEO, and its CFO over claims that the defendants failed to disclose material information to stockholders regarding the company’s application for a third-party insurance administrator license in Florida. According to the suit, the defendants admitted their application had been denied but neglected to mention that the rejection was caused by “numerous, material errors and omissions” that prompted the Office of Insurance Regulation (OIR) to conclude that the company was “not competent.”
Even further, the complaint claims the defendants hid from investors the private warning they issued to the OIR of a “disastrous domino effect” the company would experience following the denied application that would cause them to lose licenses in several other states.
The suit alleges that on September 11, 2017, SeekingAlpha.com published an article about Health Insurance Innovations that exposed the allegedly withheld information and caused stock prices to drop by 22 percent.
Hair Relaxer Lawsuits
Women who developed ovarian or uterine cancer after using hair relaxers such as Dark & Lovely and Motions may now have an opportunity to take legal action.
Read more here: Hair Relaxer Cancer Lawsuits
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.